Previous Article | Next Article ![]()
Infection and Immunity, June 2000, p. 3768-3771, Vol. 68, No. 6
Institute for Animal Health, Newbury,
Berkshire RG20 7NN,1 and Centre for
Veterinary Science, Department of Clinical Veterinary Medicine,
University of Cambridge, Cambridge CB3 0ES,2
United Kingdom
Received 13 December 1999/Returned for modification 2 February
2000/Accepted 17 March 2000
Mutation of waaN, a gene involved in lipid A
biosynthesis, reduced enteropathogenic responses induced by
Salmonella enterica serovar Typhimurium in bovine ligated
ileal loops. However, the secretion of key virulence determinants was
also reduced, and therefore the reduction in enteropathogenicity cannot
be solely attributed to a reduction in biological activity of lipid A.
Lipopolysaccharide (LPS) is the
major component of the outer leaflet of the outer membrane of
gram-negative bacteria. LPS has been described as having three
structural and functional domains: the lipid A, core, and O antigen
domains. The biological and toxic activities associated with LPS lie
within the lipid A domain. The genetic basis for lipid A biosynthesis
has largely been determined (15), allowing the construction
of defined mutations that result in bacteria synthesizing altered lipid
A structures. Previously, mutations in lipid A biosynthesis genes
resulted in conditional lethality, but recently mutations in
msbB (renamed waaN) in Escherichia coli and Salmonella enterica serovar Typhimurium which
do not affect bacterial growth have been described (11, 12,
16). htrB (renamed waaM) mutants have also
been generated which are conditional for growth at less than 32°C for
survival (17). The waaM and waaN genes
are responsible for the late acylation reactions that complete lipid A
biosynthesis. Loss of these acyl chains from lipid A reduces the
ability of the molecule to induce release of cytokines and other
mediators of the immune response (7, 9, 12, 13, 16).
In mice, mutation of waaM in serovar Typhimurium resulted in
reduced virulence and reduced growth in vivo, probably in large part
due to the temperature sensitivity of these mutants (9). Mutation of waaN led to a very different phenotype. These
mutants were able to grow at the same rate as the wild-type bacteria in murine livers and spleens following intravenous inoculation but reached
higher numbers (approximately 109 CFU per organ) than those
typically associated with death during infection with wild-type serovar
Typhimurium. Only a small proportion of the mice died, and the
surviving mice eventually cleared the infection (12). The
levels of proinflammatory cytokines and nitric oxide production were
considerably lower during the course of infection with the
waaN mutant than with the wild-type bacteria. This suggests
that death in the mouse typhoid model of infection is dependent on high
levels of cytokine release in response to lipid A.
In order to assess the role of lipid A in other Salmonella
infection systems, Everest et al. (3) tested a
waaN mutant in a rabbit ligated ileal loop model for
enteropathogenesis and found that it showed no difference compared with
wild-type serovar Typhimurium. This result was surprising in that the
mutant is reduced in its ability to induce cytokines, which have been
implicated in the induction of enteropathogenic responses (1, 2,
14). We have therefore reevaluated the role of lipid A in
Salmonella enteropathogenesis by testing the waaN
mutant in the bovine ligated ileal loop model. The results from this
model using defined isogenic bacterial mutants correlate well with the
severity of enteritis in orally inoculated calves (18, 20,
21).
Effect of mutation of waaN on induction of
enteropathogenic responses by serovar Typhimurium.
Bacteria were
incubated in bovine midileal loops for 12 h, during which time
polymorphonuclear leukocytes (PMNs) from each calf were isolated,
labeled with 111In, and reinjected. The surgical procedure
is described in detail elsewhere (18). After 12 h, the
secretory response (volume of fluid within a loop/length of loop in
milliliters per centimeter) and the
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Mutation of waaN Reduces
Salmonella enterica Serovar Typhimurium-Induced Enteritis
and Net Secretion of Type III Secretion System 1-Dependent
Proteins
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
emission of PMNs in the test
loops compared with the negative control loops (PMN influx ratio) were
recorded. The bacterial strains used, serovar Typhimurium C5 and its
derivative waaN mutant and S. enterica serovar
Dublin SD2229 and its derivative sipB mutant, have been
described previously (12, 22). The inocula were incubated
overnight in Luria-Bertani (LB) broth at 25°C and 100 rpm,
subcultured approximately 1:3 into fresh LB broth, and incubated for
2 h at 37°C and 130 rpm. The optical density of the subcultures
was adjusted by the addition of LB broth as required. The mean
inoculum ± standard error of the mean (SEM) was 9.4 ± 0.08 log10 CFU per loop, and the mean secretory response ± SEM in the negative control loops (inoculated with sterile LB broth) was 0.02 ± 0.02 ml cm
1.

View larger version (24K):
[in a new window]
FIG. 1.
Induction of enteropathogenic responses by serovar
Dublin SD2229, serovar Typhimurium C5, and derivative mutants in bovine
ligated ileal loops. (a) Secretory response. (b) Inflammatory response.
Each bar represents the mean from three ligated loops and is presented
with the SEM. WT, wild type.
The waaN mutant is impaired in secretion of proteins
required for invasion and enteropathogenesis.
Induction of
enteropathogenic responses by serovars Typhimurium and Dublin requires
the appropriate secretion and translocation of type III secretion
system-1 (TTSS-1) Salmonella invasion proteins (Sips) and
Salmonella outer proteins (Sops) (4, 10, 21). The
effect of the waaN mutation on the secretion of proteins by serovar Typhimurium was assessed. Bacterial cultures were prepared by
incubation overnight in LB broth at 25°C and 100 rpm, subculture 1:10
into fresh LB broth, and incubation for 4 h at 37°C and 130 rpm.
There were no differences in the optical densities of the cultures
(1.106 and 1.109 at 600 nm) or the number of viable bacteria (2.5 × 109 and 4.0 × 109 CFU
ml
1) between the wild-type and waaN mutant,
respectively, in a representative experiment. The culture supernatant
was obtained by centrifugation at 10,000 × g for 10 min at 4°C and filtration with 0.45-µm-pore-size disposable
filters. Proteins present in the supernatant were precipitated by the
addition of trichloroacetic acid, separated on a sodium dodecyl
sulfate-12% polyacrylamide gel, and stained with Coomassie brilliant
blue as described previously (22). Several proteins were
present in larger amounts in wild-type serovar Typhimurium C5 than in
the waaN mutant (Fig. 2) in
each of three separate experiments. Two of the most prominent of these
proteins had molecular sizes similar to those reported for SipA (87 kDa) and SipC (42 kDa) (8, 21). We have previously
demonstrated that a 42-kDa secreted protein from serovar Typhimurium is
recognized by an anti-SipC monoclonal antibody (21).
|
1) for 1 h. The monolayers
were washed twice, Int 407 cells were lysed with 0.1% deoxycholate,
and the numbers of bacteria were estimated by counting viable cells.
The invasiveness of strain C5 was significantly reduced (P < 0.001), from 4.94 ± 0.03 to 4.48 ± 0.01 log10 CFU ml
1 by mutation of waaN
in an experiment representative of a total of three, each performed in
triplicate. This reduction was complemented (4.95 ± 0.02 log10 CFU ml
1) by introducing an intact copy
of waaN in trans. The number of viable bacteria
in the inoculum for the wild-type, waaN mutant, and
waaN-complemented strains were 5.97, 6.16, and 6.18 log10 CFU ml
1, respectively. Taking the
protein secretion and invasion results together, waaN is
likely to reduce enteropathogenesis by reducing the net secretion of
TTSS-1-dependent proteins, and any direct effect of reduced lipid A
toxicity is difficult to evaluate.
The reduction in Salmonella virulence associated with
mutation of waaN cannot be attributed solely to a reduction
in cytokine induction, as was concluded in previous studies (12,
13), because of the pleiotropic effects associated with the
mutation. Even the reduction in cytokine expression following infection of mice with the waaN mutant compared to infection with
wild-type serovar Typhimurium may be the result of a nonspecific
effect, because mutation of genes associated with TTSS-1 reduces the
synthesis or activation of proinflammatory cytokines (5, 6).
Despite this postulated nonspecific effect on cytokine induction, the reduced cytokine induction by viable waaN mutants can still
be attributed, at least in part, to altered lipid A, because
experiments with heat-killed bacteria and purified LPS clearly
demonstrate that LPS from waaN mutants induces less cytokine
release than wild-type LPS (12, 13).
Perhaps the most important relevance of this study is the use of
serovar Typhimurium waaN mutants as a cancer therapeutic, in
which the tumor targeting and antitumor activities of wild-type serovar
Typhimurium are retained but with reduced toxicity (13). For
such a strain to be used in humans, the mechanism of attenuation must
be clearly defined. The results of this study, demonstrating the
pleiotropic effects associated with mutation of waaN,
contribute significantly to our understanding of this attenuation.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by the Ministry for Agriculture, Food and Fisheries, grant contract number OZ0308, and two Biological and Biotechnological Science Research Council grants, numbers 201/510274 and 8/D09660.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Institute for Animal Health, Compton, Newbury, Berkshire RG20 7NN, United Kingdom. Phone: 44 1635 577230. Fax: 44 1635 577263. E-mail: timothy.wallis{at}bbsrc.ac.uk.
Editor: A. D. O'Brien
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Arnold, J. W.,
D. W. Niesel,
C. R. Annable,
C. B. Hess,
M. Asuncion,
Y. J. Cho,
J. W. Peterson, and G. R. Klimpel.
1993.
Tumor necrosis factor- mediates the early pathology in Salmonella infection of the gastrointestinal tract.
Microbiol. Pathog.
14:217-227.
|
| 2. | Eckmann, L., M. F. Kagnoff, and J. Fierer. 1995. Intestinal epithelial cells as watchdogs for the natural immune system. Trends Microbiol. 3:118-120[CrossRef][Medline]. |
| 3. |
Everest, P.,
J. Ketley,
S. Hardy,
G. Douce,
S. Khan,
J. Shea,
D. Holden,
D. Maskell, and G. Dougan.
1999.
Evaluation of Salmonella typhimurium mutants in a model of experimental gastroenteritis.
Infect. Immun.
67:2815-2821 |
| 4. | Galyov, E. E., M. W. Wood, R. Rosqvist, P. B. Mullan, P. R. Watson, S. Hedges, and T. S. Wallis. 1997. A secreted effector protein of Salmonella dublin is translocated into eukaryotic cells and mediates inflammation and fluid secretion in infected ileal mucosa. Mol. Microbiol. 25:903-912[CrossRef][Medline]. |
| 5. |
Hersh, D.,
D. M. Monack,
M. R. Smith,
N. Ghori,
S. Falkow, and A. Zychlinsky.
1999.
The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1.
Proc. Natl. Acad. Sci. USA
96:2396-2401 |
| 6. | Hobbie, S., L. M. Chen, R. J. Davis, and J. E. Galán. 1997. Involvement of mitogen-activated protein kinase pathways in the nuclear responses and cytokine production induced by Salmonella typhimurium in cultured intestinal epithelial cells. J. Immunol. 157:5550-5559. |
| 7. |
Hone, D. M.,
J. Powell,
R. W. Crowley,
D. Maneval, and G. K. Lewis.
1998.
Lipopolysaccharide from an Escherichia coli htrB msbB mutant induced high levels of MIP-1 secretion without inducing TNF- and IL-1 .
J. Human Virol.
1:251-256[Medline].
|
| 8. | Hueck, C. J., M. J. Hantman, V. Bajaj, C. Johnston, C. A. Lee, and S. I. Miller. 1995. Salmonella typhimurium secreted invasion determinants are homologous to Shigella Ipa proteins. Mol. Microbiol. 18:479-490[CrossRef][Medline]. |
| 9. | Jones, B. D., W. A. Nichols, B. W. Gibson, M. G. Sunshine, and M. A. Apicella. 1997. Study of the role of the htrB gene in Salmonella typhimurium virulence. Infect. Immun. 65:4778-4783[Abstract]. |
| 10. |
Jones, M. A.,
M. W. Wood,
P. B. Mullan,
P. R. Watson,
T. S. Wallis, and E. E. Galyov.
1998.
Secreted effector proteins of Salmonella dublin act in concert to induce enteritis.
Infect. Immun.
66:5799-5804 |
| 11. |
Karrow, M., and C. Georgopoulos.
1992.
Isolation and characterization of the Escherichia coli msbB gene, a multicopy suppressor of null mutations in the high-temperature-requirement gene htrB.
J. Bacteriol.
174:702-710 |
| 12. | Khan, S., P. Everest, S. Servos, N. Foxwell, U. Zähringer, H. Brade, E. T. Rietschel, G. Dougan, I. G. Charles, and D. J. Maskell. 1998. A lethal role for lipid A in Salmonella infections. Mol. Microbiol. 29:571-579[CrossRef][Medline]. |
| 13. |
Low, K. B.,
M. Ittensohn,
T. Le,
J. Platt,
S. Sodi,
M. Amoss,
O. Ash,
E. Carmichael,
A. Chakraborty,
J. Fischer,
S. L. Lin,
X. Luo,
S. I. Miller,
L. Zheng,
I. King,
J. M. Pawelek, and D. Bermudes.
1999.
Lipid A mutant Salmonella with suppressed virulence and TNF induction retain tumor-targeting in vivo.
Nat. Biotechnol.
17:37-41[Medline].
|
| 14. | McAlindon, M. E., and Y. R. Mahida. 1997. Cytokines and the gut. Eur. J. Gastroenterol. Hepatol. 9:1045-1050[Medline]. |
| 15. | Rick, P. D., and C. R. H. Raetz. 1999. Microbial pathways of lipid A biosynthesis, p. 283-304. In H. Brade, S. M. Opal, S. N. Vogel, and D. C. Morrison (ed.), Endotoxin in health and disease. Marcel Dekker Inc., New York, N.Y. |
| 16. | Somerville, J. E., L. Cassiano, B. Bainbridge, M. D. Cunningham, and R. P. Darveau. 1996. A novel Escherichia coli lipid A mutant that produced an antiinflammatory lipopolysaccharide. J. Clin. Investig. 97:359-365[Medline]. |
| 17. |
Sunshine, M. G.,
B. W. Gibson,
J. J. Engstrom,
W. A. Nichols,
B. D. Jones, and M. A. Apicella.
1997.
Mutation of the htrB gene in a virulent Salmonella typhimurium strain by intergeneric transduction: strain construction and phenotype characterization.
J. Bacteriol.
179:5521-5533 |
| 18. | Wallis, T. S., S. M. Paulin, J. S. Plested, P. R. Watson, and P. W. Jones. 1995. The Salmonella dublin virulence plasmid mediates systemic but not enteric phases of salmonellosis in cattle. Infect. Immun. 63:2755-2761[Abstract]. |
| 19. | Wallis, T. S., R. J. H. Hawker, D. C. A. Candy, G.-M. Qi, G. J. Clarke, K. J. Worton, M. P. Osborne, and J. Stephen. 1989. Quantification of the leukocyte influx into rabbit ileal loops induced by strains of Salmonella typhimurium of different virulence. J. Med. Microbiol. 30:149-156[Abstract]. |
| 20. |
Watson, P. R.,
S. M. Paulin,
A. P. Bland,
S. J. Libby,
P. W. Jones, and T. S. Wallis.
1999.
Differential regulation of enteric and systemic salmonellosis by slyA.
Infect. Immun.
67:4950-4954 |
| 21. |
Watson, P. R.,
E. E. Galyov,
S. M. Paulin,
P. W. Jones, and T. S. Wallis.
1998.
Mutation of invH but not stn reduced Salmonella-induced enteritis in cattle.
Infect. Immun.
66:1432-1438 |
| 22. | Wood, M. W., R. Rosqvist, P. B. Mullan, M. H. Edwards, and E. E. Galyov. 1996. SopE, a secreted protein of Salmonella dublin, is translocated into the target eukaryotic cell via a sip-dependent mechanism and promotes bacterial entry. Mol. Microbiol. 22:327-338[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|